C R Lyttle
Overview
Explore the profile of C R Lyttle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lyttle C, Komm B, Cheskis B
Ernst Schering Res Found Workshop
. 2004 Jul;
(46):1-21.
PMID: 15248501
No abstract available.
2.
Komm B, Lyttle C
Ann N Y Acad Sci
. 2002 Jan;
949:317-26.
PMID: 11795370
Estrogens are represented by a diverse group of compounds. Within this large family of molecules are tissue-selective estrogens that have been classified as selective estrogen receptor modulators (SERMs). These compounds...
3.
Greenberger L, Annable T, Collins K, Komm B, Lyttle C, Miller C, et al.
Clin Cancer Res
. 2001 Oct;
7(10):3166-77.
PMID: 11595711
Purpose: Tamoxifen is an antiestrogen used in women who have estrogen receptor (ER)-alpha-positive breast cancer. Unfortunately, resistance to tamoxifen is common in women with metastatic disease and side effects, including...
4.
Schwartz L, Naftolin F, Lyttle C, Penzias A, Meaddough E, Kliman H
J Soc Gynecol Investig
. 2001 Aug;
8(4):216-23.
PMID: 11525897
Objective: To study the regulation of the blood group A-related high-molecular weight mucin glycoprotein epitope (mouse ascites golgi, MAG)-a menstrual cycle-dependent marker of endometrial receptivity-in a non-human endometrium model. Methods:...
5.
Miller C, Collini M, Tran B, Harris H, Kharode Y, Marzolf J, et al.
J Med Chem
. 2001 May;
44(11):1654-7.
PMID: 11356100
No abstract available.
6.
Harnish D, Scicchitano M, Adelman S, Lyttle C, Karathanasis S
Endocrinology
. 2000 Aug;
141(9):3403-11.
PMID: 10965913
Functional interactions or cross-talk between ligand-activated nuclear receptors and the proinflammatory transcription factor nuclear factor-kappaB (NF-kappaB) may play a major role in ligand-mediated modification of diseases processes. In particular, the...
7.
Dey M, Lyttle C, Pickar J
Maturitas
. 2000 Aug;
34 Suppl 2:S25-33.
PMID: 10915919
Recent advances have added substantially to our understanding of the biology of estrogens. Estrogens are no longer considered to differ only in potency. Two estrogens can have similar effects in...
8.
Roper R, Griffith J, Lyttle C, Doerge R, McNabb A, Broadbent R, et al.
Endocrinology
. 1999 Feb;
140(2):556-61.
PMID: 9927277
The steroid hormone estradiol (E2) elicits a spectrum of systemic and uterotropic responses in vivo. For example, E2 treatment of ovariectomized adult and sexually immature rodents leads to uterine leukocytic...
9.
Bhat R, Harnish D, Stevis P, Lyttle C, Komm B
J Steroid Biochem Mol Biol
. 1999 Jan;
67(3):233-40.
PMID: 9879982
A novel human estrogen receptor beta (hERbeta) was cloned from human testis mRNA, ovary and thymus cDNA utilizing PCR and 5' RACE methods. The 5' end of hERbeta contained an...
10.
Suen C, Berrodin T, Mastroeni R, Cheskis B, Lyttle C, Frail D
J Biol Chem
. 1998 Oct;
273(42):27645-53.
PMID: 9765300
Estrogen receptors ERalpha and ERbeta are members of the family of nuclear hormone receptors and act as ligand-inducible transcriptional factors, which regulate the expression of target genes on binding to...